生物藥學研究所

Keyphrases

1. 5-fluorouracil (5-FU) 29%
2. 95% Confidence Interval 36%
3. Ablation 41%
4. Activator of Transcription 3 17%
5. Acute Myeloid Leukemia 28%
6. Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) 19%
7. Antisense Oligonucleotides 17%
8. Apoptosis 36%
9. Apoptosis Induction 60%
10. Atrial Fibrillation 100%
11. Atrial Fibrillation Ablation 37%
12. Atrial Fibrillation Patient 35%
13. Aurora A 18%
14. Autophagy 22%
15. B-cell Lymphoma 2 (Bcl-2) 22%
16. Blowing Agent 16%
17. Caenorhabditis Elegans 27%
18. Carbon Dioxide 29%
19. Carbon Nanofibers 37%
20. Catheter Ablation 77%
21. CHA2DS2-VASc Score 20%
22. Chemotherapy 33%
23. Chronic Graft-versus-host Disease (cGVHD) 16%
24. CIP2A 26%
25. Cisplatin 19%
26. Clinical Outcomes 17%
27. Colorectal Cancer 23%
28. Cytotoxicity 16%
29. D-Serine Dehydratase 16%
30. Diffuse Large B-cell Lymphoma (DLBCL) 20%
31. Electrophysiological Activity 16%
32. Electroporation 16%
33. Extracellular Vesicles 18%
34. Fiber Mats 21%
35. Free Radicals 19%
36. Gene Expression 24%
37. Glass Transition Temperature 21%
38. Hazard Ratio 22%
39. Head-and-neck Squamous Cell Carcinoma (HNSCC) 26%
40. Hematopoietic Stem Cell Transplantation 18%
41. Hepatocellular Carcinoma 70%
42. Hepatocellular Carcinoma Cells 31%
43. In Cancer 17%
44. Injection Molding 27%
45. Interpenetrating Polymer Network 17%
46. Knockdown 23%
47. Leucovorin 19%
48. Leukemia 17%
49. Lipoplexes 18%
50. Liquid Composite Molding 23%
51. Liver 22%
52. Low Temperature 26%
53. Lung Cancer 18%
54. Mechanical Properties 22%
55. Metastatic Colorectal Cancer (mCRC) 28%
56. MicroRNA 22%
57. Mold Filling 34%
58. Multivariate Analysis 23%
59. Nanoclay 29%
60. Nanopaper 25%
61. Nanoparticles 44%
62. Non-Hodgkin Lymphoma 30%
63. Non-small Cell Lung Cancer (NSCLC) 20%
64. Overall Survival 32%
65. Overexpression 33%
66. Paroxysmal Atrial Fibrillation 40%
67. Persistent Atrial Fibrillation 34%
68. Phosphorylation 21%
69. Poly(methyl methacrylate) 21%
70. Polyester 18%
71. Polystyrene 60%
72. Polyurethane 24%
73. Prognostic Factors 24%
74. Protein Phosphatase 2A (PP2A) 18%
75. Protein-protein Interaction 18%
76. Pulmonary Vein Isolation 29%
77. Reaction Injection Molding 19%
78. Reaction Kinetics 22%
79. Reaction Rate 17%
80. Resin 41%
81. Resin Transfer Molding 22%
82. Risk Factors 24%
83. Rituximab 18%
84. Sheet Molding Compound 21%
85. SHP-1 49%
86. Signal Transducer 19%
87. Small Interfering RNA (siRNA) 34%
88. Sorafenib 37%
89. Structural Reaction Injection Moulding 19%
90. Styrene 18%
91. Taipei 16%
92. Taiwan 66%
93. Targeted Delivery 16%
94. Thymosin 16%
95. Tumor 25%
96. Unsaturated Polyester 18%
97. Unsaturated Polyester Resin 48%
98. Ventricular Arrhythmia 26%
99. Viscosity 16%
100. Zebrafish 26%